Frequency of Variant of Gullian-Barré Syndrome (GBS) in Bolan Medical Complex Hospital, Quetta

Authors

  • Hussain Ahmed Department of Neurology, Bolan Medical Complex Hospital, Quetta, Pakistan
  • Noor Ahmed Khosa Department of Neurology, Bolan Medical Complex Hospital, Quetta, Pakistan
  • Muhammad Essa Department of Neurology, Bolan Medical Complex Hospital, Quetta, Pakistan
  • Sur Gul Department of Neurology, Bolan Medical Complex Hospital, Quetta, Pakistan
  • Abdul Ali Department of Neurology, Bolan Medical Complex Hospital, Quetta, Pakistan
  • Sara Mandokhail Department of Neurology, Bolan Medical Complex Hospital, Quetta, Pakistan

DOI:

https://doi.org/10.70749/ijbr.v3i6.2523

Keywords:

Guillain-Barré Syndrome, Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP), Acute Motor Axonal Neuropathy (AMAN), Acute Motor-Sensory Axonal Neuropathy (AMSAN), Miller Fisher Syndrome (MFS), Campylobacter jejuni.

Abstract

Background: Guillain-Barré Syndrome (GBS) is a heterogeneous immune-mediated neuropathy with varying clinical and electrophysiological variants. This study investigates the frequency and characteristics of GBS variants in Quetta, Pakistan. Methods: A prospective cross-sectional study was conducted at Bolan Medical Complex Hospital from November 2024 to April 2025, enrolling 67 patients aged ≥12 years meeting Brighton Criteria for GBS. Data on demographics, clinical features, electrophysiological findings, and outcomes were analyzed using R software, with statistical significance set at p<0.05. Results: AIDP was the most common variant (46.3%, 95% CI: 34.2–58.8%), followed by AMAN (26.9%), AMSAN (11.9%), MFS (9.0%), and PCB (4.5%). Axonal variants (38.8%) were prevalent, linked to Campylobacter jejuni in 23.1% of cases (OR 5.2, p=0.003). Poor outcomes (HDS ≥4) occurred in 34.3%, with axonal variants (OR 3.8, p=0.023), mechanical ventilation (OR 8.5, p<0.001), age >60 years (OR 4.1, p=0.016), and rapid progression (OR 2.9, p=0.049) as predictors. AMAN showed prolonged recovery (42 days) versus AIDP (28 days, p=0.002). Conclusion: The high prevalence of axonal variants in Quetta underscores the need for tailored diagnostic and therapeutic strategies in resource-limited settings.

Downloads

Download data is not yet available.

References

1. Leonhard, S.E., et al., Guillain–Barré syndrome. Nature Reviews Disease Primers, 2024. 10(1): p. 97.

https://doi.org/10.1038/s41572-024-00580-4

2. Parveen, S., et al., Unmasking Guillain-Barre Syndrome: From Triggers to Treatment. International Journal of Innovative Science and Research Technology, 2025. 10(6): p. 330-341.

https://doi.org/10.38124/ijisrt/25jun078

3. Elendu, C., et al., Clinical presentation and symptomatology of Guillain-Barré syndrome: A literature review. Medicine, 2024. 103(30): p. e38890.

https://doi.org/10.1097/md.0000000000038890

4. Bragazzi, N.L., et al., Global, regional, and national burden of Guillain–Barré syndrome and its underlying causes from 1990 to 2019. Journal of neuroinflammation, 2021. 18: p. 1-11.

https://doi.org/10.1186/s12974-021-02319-4

5. Haq, M.A.U., et al., A Diagnostic Pattern in Guillain-Barré Syndrome (GBS) in Children a Multi-Center Study. Pakistan Journal of Medical & Health Sciences, 2022. 16(12): p. 400-400.

https://doi.org/10.53350/pjmhs20221612400

6. Ali, S. and S. Saeed, Prevalence Of Guillain-Barre Syndrome In Acute Flaccid Paralysis In Patients Presented To Pediatric Ward Civil Hospital Sukkur. 2025.

7. Kwan, J. and S. Biliciler, Guillain-Barré syndrome and other acute polyneuropathies. Clinics in Geriatric Medicine, 2021. 37(2): p. 313-326.

https://doi.org/10.1016/j.cger.2021.01.005

8. Zaeem, Z., Z.A. Siddiqi, and D.W. Zochodne, Autonomic involvement in Guillain–Barré syndrome: an update. Clinical Autonomic Research, 2019. 29: p. 289-299.

https://doi.org/10.1007/s10286-018-0542-y

9. Shang, P., et al., Axonal variants of Guillain–Barré syndrome: an update. Journal of neurology, 2021. 268(7): p. 2402-2419.

https://doi.org/10.1007/s00415-020-09742-2

10. Doets, A.Y., et al., Regional variation of Guillain-Barré syndrome. Brain, 2018. 141(10): p. 2866-2877.

https://doi.org/10.1097/wco.0000000000000602

11. Hiew, F.L., et al., Guillain-Barré Syndrome, variants & forms fruste: Reclassification with new criteria. Clinical Neurology and Neurosurgery, 2017. 158: p. 114-118.

https://doi.org/10.1016/j.clineuro.2017.05.006

12. Dimachkie, M.M. and R.J. Barohn, Guillain-Barré syndrome and variants. Neurologic clinics, 2013. 31(2): p. 491.

https://doi.org/10.1016/j.ncl.2013.01.005

13. Winer, J., Guillain–Barré syndrome: Clinical variants and their pathogenesis. Journal of neuroimmunology, 2011. 231(1-2): p. 70-72.

https://doi.org/10.1016/j.jneuroim.2010.09.017

14. Michel-Chávez, A., et al., Predictors of Mechanical Ventilation in Guillain–Barré Syndrome with Axonal Subtypes. Canadian Journal of Neurological Sciences, 2023. 50(2): p. 221-227.

https://doi.org/10.1017/cjn.2022.19

15. Haque, A.B.M.M., et al., Electrophysiological Subtypes of Guillain-Barre Syndrome in the Bangladeshi Population: A Cross-Sectional Study. TAJ: Journal of Teachers Association, 2025. 38(2): p. 12-19.

https://doi.org/10.70818/taj.v038i02.0286

16. Bae, J.S., et al., Guillain–barré syndrome in asia. Journal of Neurology, Neurosurgery & Psychiatry, 2014. 85(8): p. 907-913.

https://doi.org/10.1136/jnnp-2013-306212

17. Khadilkar, S.V., R.S. Yadav, and B.A. Patel, Acute Motor Axonal Neuropathy (AMAN), in Neuromuscular Disorders: A Comprehensive Review with Illustrative Cases. 2024, Springer. p. 123-128.

https://doi.org/10.1007/978-981-97-9010-4_11

18. Luna-Mendez, J.-A., Epidemiological and clinical variability of amyotrophic lateral sclerosis between geographic areas and populations: focus on Africa and Latin America. 2019, Université de Limoges.

19. Katz, D.I., et al., National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome. Neurology, 2021. 96(18): p. 848-863.

https://doi.org/10.1212/wnl.0000000000011850

20. Tunç, A., Early predictors of functional disability in Guillain-Barré Syndrome. Acta Neurol Belg, 2019. 119(4): p. 555-559.

https://doi.org/10.1007/s13760-019-01133-3

21. ul Haq, M.A., et al., Frequency, Age, Gender Distribution, and Seasonal Variation of Guillain-Barré Syndrome in a Province of Pakistan: A Retrospective Study: Prevalance of Guillain-Barre Syndrome. Pakistan Journal of Health Sciences, 2023: p. 207-210.

https://doi.org/10.54393/pjhs.v4i03.565

22. ul Haq, M.A., et al., Clinical and demographic characteristics of guillain-barré syndrome (GBS) variants in a tertiary care hospital. The Professional Medical Journal, 2023. 30(07): p. 851-855.

https://doi.org/10.29309/tpmj/2023.30.07.7494

23. Chen, Y.-H., et al., Incidence and characteristics of Guillain–Barré syndrome in Taiwan before and during the COVID-19 pandemic: A 12-year single-center experience. Journal of the Chinese Medical Association, 2025. 88(7): p. 503-512.

https://doi.org/10.1097/jcma.0000000000001251

24. Papri, N., et al., Guillain–Barré syndrome in low-income and middle-income countries: challenges and prospects. Nature Reviews Neurology, 2021. 17(5): p. 285-296.

https://doi.org/10.1038/s41582-021-00467-y

25. Maini, D.K., et al., A retrospective observational study of clinical and electrophysiological types of Guillain-Barre syndrome from Delhi. J Family Med Prim Care, 2025. 14(6): p. 2231-2236.

https://doi.org/10.4103/jfmpc.jfmpc_1747_24

26. Khosa, N.A., et al., Plasma-exchange therapy in acute immune-mediated neuropathy: Effects on muscle strength and functional outcomes. Romanian JouRnal of neuRology, 2024. 23(2): p. 160.

https://doi.org/10.37897/rjn.2024.2.12

27. Xu, L., et al., Variation in worldwide incidence of Guillain-Barré syndrome: a population-based study in urban China and existing global evidence. Front Immunol, 2024. 15: p. 1415986.

https://doi.org/10.3389/fimmu.2024.1415986

28. Khan, S.A., et al., An updated review on Guillain-Barré syndrome: Challenges in infection prevention and control in low- and middle-income countries. SAGE Open Medicine, 2024. 12: p. 20503121241239538.

https://doi.org/10.1177/20503121241239538

29. Rafique, M., et al., Clinical Profile and Predictors of Outcome of Guillain Barre Syndrome Variants among Children Admitted in the Pediatric Department of a Tertiary Care Hospital, Karachi. National Journal of Health Sciences, 2023. 8(3): p. 117-122.

https://doi.org/10.21089/njhs.83.0117

30. Van Doorn, P.A., et al., European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of Guillain–Barré syndrome. Journal of the Peripheral Nervous System, 2023. 28(4): p. 535-563.

https://doi.org/10.1111/ene.16230

Downloads

Published

2025-06-30

How to Cite

Ahmed, H., Khosa, N. A., Muhammad Essa, Sur Gul, Abdul Ali, & Mandokhail, S. (2025). Frequency of Variant of Gullian-Barré Syndrome (GBS) in Bolan Medical Complex Hospital, Quetta. Indus Journal of Bioscience Research, 3(6), 1206-1211. https://doi.org/10.70749/ijbr.v3i6.2523